COVID-19 Research Specific Information

COVID-19 virus

  • UPDATE: Expanding Laboratory Research (added May 14, 2021)
  • How to Submit Campus Access Requests
    Researchers requesting access to campus on behalf of new team members should use this electronic form. The GMS portal used previously for such requests has been retired. Requests may be submitted singly or as a file with multiple requests.
  • COVID-19 and Human Subjects Research Guidance and FAQs
    In order to sustain our human subject research during the COVID-19 pandemic, guidelines have been issued jointly by the Medstar Health and Georgetown University for the benefit of investigators and associated staff in both institutions. View the guidelines here.

GUMC COVID-19 Call for Research Proposals: We would like to determine who on our campus has a great idea to carry out COVID-19 relevant research but cannot do so because of current research continuity policies. This would include dry lab, wet lab and clinical trial research. Many of our peer institutions have doubled down on such research, even as they take appropriate social distancing precautions that limit other forms of research activity.  As a research university, we have an obligation to be part of the solution if we have the capacity to contribute.

We will be offering a group brainstorming session, via Zoom, on Monday, March 30th at 1PM for those who are interested. 

If you have a high-priority COVID-19 focused project in mind, please submit a one-two page proposal by Wednesday, April 1st. We will select the most promising proposals, and will work with successful applicants to determine how to best execute the project in their laboratories while adhering to appropriate social distancing requirements. Exemptions to current research continuity guidelines will be granted ONLY to successful applicants. 

Do not submit budgets with these submissions. Small amounts of funding (personnel costs are not permitted) may be available for well justified critical supplies or reagents for proposals that are selected for further consideration. We anticipate supporting no more than five meritorious proposals using this mechanism.

Criteria for successful applications will be:

Relevance to COVID-19 pandemic

Potential impact of the work

Feasibility, including potential for rapid clinical translation

Quality of the science


Other Organizations’ COVID-19 pages, resources, and announcements